Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
         L04AA02 Muromonab-CD3
         L04AA03 Antilymphocyte immunoglobulin (horse)
         L04AA04 Antithymocyte immunoglobulin (rabbit)
         L04AA06 Mycophenolic acid
         L04AA10 Sirolimus
         L04AA13 Leflunomide
         L04AA15 Alefacept
         L04AA18 Everolimus
         L04AA19 Gusperimus
         L04AA21 Efalizumab
         L04AA22 Abetimus
         L04AA23 Natalizumab
         L04AA24 Abatacept
         L04AA25 Eculizumab
         L04AA26 Belimumab
           D03068  Belimumab (genetical recombination) (JAN); Belimumab (USAN)
         L04AA27 Fingolimod
         L04AA28 Belatacept
         L04AA29 Tofacitinib
         L04AA31 Teriflunomide
         L04AA32 Apremilast
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
       L04AC Interleukin inhibitors
       L04AD Calcineurin inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 3, 2014
According to WHO's ATC 2014

» Japanese version